Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Journal of Applied Clinical Medical Physics|December 25, 2015
AAPM Medical Physics Practice Guideline 5.a.: Commissioning and QA of Treatment Planning Dose Calculations - Megavoltage Photon and Electron BeamsJennifer B Smilowitz, Indra J Das, Vladimir Feygelman, et al.
Practical Radiation Oncology|November 22, 2014
Contouring variations and the role of atlas in non-small cell lung cancer radiation therapy: Analysis of a multi-institutional preclinical trial planning studyYunfeng Cui, Wenzhou Chen, Feng-Ming Spring Kong, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 11, 2014
Dose to the inferior rectum is strongly associated with patient reported bowel quality of life after radiation therapy for prostate cancerMatthew H Stenmark, Anna S C Conlon, Skyler Johnson, et al.
Medical Physics|October 3, 2015
Automating linear accelerator quality assuranceTobias Eckhause, Hania Al-Hallaq, Timothy Ritter, et al.
Crohn'S & Colitis 360|July 30, 2025
Impact of Precision-Guided Dosing on Clinical Decision-Making and Health Care Utilization in Inflammatory Bowel Disease: A Retrospective Pretest/Posttest Real-World StudyRonen Arai, Adria Condino, Bincy P Abraham, et al.
Inflammatory Bowel Diseases|September 26, 2025
Long-Term Ozanimod Therapy in Patients With Moderately Active Ulcerative Colitis After Failure of 5-Aminosalicylic AcidAndres Yarur, Peter Irving, Britta Siegmund, et al.
Inflammatory Bowel Diseases|December 10, 2024
Mediators of Filgotinib Treatment Effects in Ulcerative Colitis: Exploring Circulating Biomarkers in the Phase 2b/3 SELECTION StudyHiroshi Nakase, Silvio Danese, Walter Reinisch, et al.
Gastrointestinal Endoscopy|October 19, 2024
Endoscopic diagnosis and management of adult inflammatory bowel disease: a consensus document from the American Society for Gastrointestinal Endoscopy IBD Endoscopy Consensus Panel, Bo Shen, Maria T Abreu, et al.
The Lancet. Gastroenterology & Hepatology|November 19, 2021
Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 studySeverine Vermeire, Peter L Lakatos, Timothy Ritter, et al.
The American Journal of Gastroenterology|September 16, 2022
Rapid and Sustained Symptom Relief in Patients With Ulcerative Colitis Treated With Filgotinib: Data From the Phase 2b/3 SELECTION TrialSilvio Danese, Marc Ferrante, Brian G Feagan, et al.
Pageof 5